Global News Aggregator
It was a tough, choppy week for stocks, but the oversold market gave us many opportunities. Source link: https://www.cnbc.com/2024/04/21/added-to-5-portfolio-stocks-in-oversold-market-bby-ctra-stz-abt-el.html
Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Friday’s key moments. Both the S & P…
Abbott Laboratories delivered a top and bottom line beat Wednesday and surprised investors by raising its full-year guidance — a show of confidence by the medical device maker not seen…
Eli Lilly ‘s weight-loss drug Zepbound showed promise as a treatment for sleep apnea — giving investors more confidence to keep owning the world’s most valuable health-care company even after…
U.S. oil prices have climbed to their highest level since late October, as the rally in the key commodity becomes something equity investors cannot afford to look past. West Texas…
Shortly after the opening bell, we will be buying 140 shares of Abbott Laboratories at roughly $112. Following the trade, Jim Cramer’s Charitable Trust will own 700 shares of ABT,…
Nvidia’s next-generation graphics processor for artificial intelligence, called Blackwell, will cost between $30,000 and $40,000 per unit, CEO Jensen Huang told CNBC’s Jim Cramer on Tuesday on “Squawk on the…
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. (We’re…
CNBC’s Jim Cramer said Tuesday that Elon Musk’s disclosure that he takes prescription ketamine for depression was courageous and “saved a lot of people from killing themselves.” “I defend him…
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. (We’re…